Major Interest in Shares

RNS Number : 7161S
Alliance Pharma PLC
22 May 2009
 



For immediate release

22 May 2009


ALLIANCE PHARMA PLC

('the Company')


Major Interest in Shares


Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 22 May 2009
that Nigel Wray purchased, on 21 May 2009, a further 1,800,000 ordinary shares of 1p each in the Company
Mr Wra
y's resultant shareholding is 16,669,995 ordinary shares, equivalent to 10.29% of the Company's 
issued share capital.


Mr Wray's ordinary shares are held as follows:


Nominee

Number of ordinary shares


Pershing Keen Nominees Limited

Smith & Williamson Nominees Limited

RBC Dexia London Account 22607



4,799,407

50,000

11,820,588

                    

         

     


For further information: 


 

 

Alliance Pharma plc
+ 44 (0) 1249 466966
John Dawson, Chief Executive
 
Richard Wright, Finance Director

 
 

 

 

 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic

 

 

 
Numis Securities Limited
+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
 
Corporate Broking: David Poutney

 


Notes to editors


About Alliance Pharma

Alliance Pharma, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, WiltshireUK. The company has a strong track record of acquiring the rights to established niche brands and owns, or licenses, the rights to 35 branded pharmaceutical products and continues to explore opportunities to expand the range.


Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in the treatment of dermatological conditions, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.


Alliance Pharma joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLSESFSESUSEFI
UK 100

Latest directors dealings